General Atlantic invests in U.S. Urology Partners to enhance its growth and support independent community-based urology practices.

Target Information

U.S. Urology Partners (the "Company") has made significant strides in supporting independent, community-based urology practices since its establishment in 2018. The Company’s primary objective is to help urology practices retain their independence while delivering high-quality healthcare to patients within their local communities. To achieve this, U.S. Urology Partners provides its affiliated practices with substantial expertise in business operations, data analysis, and technological infrastructure designed to enhance patient outcomes and satisfaction. Furthermore, the Company focuses on alleviating the administrative burdens that often lead to provider burnout, thereby enabling doctors to concentrate on patient care.

As part of its commitment to advancing clinical excellence, U.S. Urology Partners invests in comprehensive clinical capabilities addressing both genitourinary oncology—particularly in the treatment of prostate, kidney, and bladder cancers—and various non-oncological treatment pathways. These cancer types alone account for nearly 500,000 new cases reported annually in the United States, making the Company’s role in this field particularly crucial.

Industry Overview

The urology sector in the United States is witnessing a growing trend towards community-based practices seeking to maintain their independence amidst increasing pressures from larger healthcare systems. This desire for autonomy stems primarily from the need to ensure quality patient ca